ÂÜÀòÂÒÂ×

MBA (Manchester Business School), BE (University College Dublin)

Donal was appointed to the Board of nib holdings limited in March 2016. He is Chair of the Investment Committee, and a member of the Risk and Reputation Committee, People and Remuneration Committee, and Nomination Committee.

He is also a Director of nib health funds limited. Donal has a deep knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors.

Starting his career as a qualified civil engineer, he went on to gain experience in business, science, engineering, manufacturing, and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, gaining a sound understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson & Johnson) – initially as European President and later, when he was located in the US, he served as Worldwide President.

In his role as a member of the nib Risk and Reputation Committee, Donal has a strong interest in environmental, social, and governance factors and how these performance indicators can help promote long-term financial success.

Donal is a Non-Executive Director of Mesoblast Ltd (Chair of the Nomination and Remuneration Committee) and Fisher & Paykel Healthcare Corporation Ltd.